| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $564.2M | +17.0% |
| R&D Expense | $44.5M | -11.4% |
| SG&A Expense | $326.2M | +10.8% |
| Operating Income | $44.7M | +3583.6% |
| Pre-tax Income | $47.0M | +1773.3% |
| Income Tax | $9.9M | +370.9% |
| Net Income | $37.0M | +4201.0% |
| EPS (Basic) | $0.16 | +1700.0% |
| EPS (Diluted) | $0.15 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.7M | -30.9% |
| Accounts Receivable | $217.5M | +97.9% |
| Inventory | $29.6M | +13.0% |
| Current Assets | $362.2M | +26.7% |
| Total Assets | $598.7M | +20.3% |
| Current Liabilities | $100.1M | +29.2% |
| Total Liabilities | $164.8M | +46.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | -172.6% |
| Capital Expenditures | $14.2M | +41.1% |
| Investing Cash Flow | -$14.2M | -41.1% |
| Financing Cash Flow | -$17.4M | -162.8% |
| Free Cash Flow | -$24.5M | -685.7% |
| +1600.0% |
| Stockholders' Equity |
| $300.1M |
| +14.2% |